-
公开(公告)号:US09730987B2
公开(公告)日:2017-08-15
申请号:US14632863
申请日:2015-02-26
Applicant: MERIAL INC.
Inventor: Noel Joseph Francois Detraz , Guillaume Rigaut
IPC: A61K39/00 , A61K47/26 , A61K9/00 , A61K9/107 , A61K45/06 , A61K47/06 , C12N7/00 , A61K39/39 , A61K39/02 , A61K39/12 , A61K39/135 , A61K39/125
CPC classification number: A61K39/00 , A61K9/0019 , A61K9/107 , A61K39/0241 , A61K39/12 , A61K39/125 , A61K39/135 , A61K39/39 , A61K45/06 , A61K47/06 , A61K47/26 , A61K2039/52 , A61K2039/525 , A61K2039/5252 , A61K2039/54 , A61K2039/552 , A61K2039/55505 , A61K2039/55566 , A61K2039/55577 , C12N7/00 , C12N2750/00022 , C12N2750/00034 , C12N2750/10034 , C12N2770/32022 , C12N2770/32134
Abstract: The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified (crude extracts) or minimally purified. The emulsion of the present invention can act as vehicle for the delivery of a pharmaceutical composition comprising at least one immunogen and, in particular, an immunogen selected from the group consisting of an inactivated pathogen, an attenuated pathogen, a subunit, a recombinant expression vector, and a plasmid or combinations thereof.
-
2.
公开(公告)号:US20170296577A1
公开(公告)日:2017-10-19
申请号:US15487323
申请日:2017-04-13
Applicant: MERIAL INC. , GENZYME CORPORATION
IPC: A61K31/787 , A61K39/12 , A61K31/444 , A61K39/04 , C12N7/00 , A61K39/00
Abstract: The present invention relates to non-mercurial preservatives, including antimicrobial polyamide polymers and octenidine, and to methods of use thereof to produce preservative-containing multi-dose formulations. The preservative-containing multi-dose formulations exhibit resistance to one or more contaminating microorganisms, and have advantageous properties with respect to long term stability of biological and small molecule active ingredients.
-
3.
公开(公告)号:US20170360923A1
公开(公告)日:2017-12-21
申请号:US15624405
申请日:2017-06-15
Applicant: MERIAL INC. , SANOFI PASTEUR
Inventor: Guillaume Rigaut , Alexis Guy André Lucien Parisot , Karelle De Luca , Christine Michele Pierrette Andreoni , Lydie Remolue , Marie Garinot , Jean-François Cotte , Patricia Probeck-Quellec , Jean Haensler , Véronique Chambon , Philippe Talaga
Abstract: The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.
-
-